Please Wait

Applying Filters...

Sevelamer
JDMF
Table View

Top first-in-class drug candidates of 2025: Ionis’ donidalorsen, Sanofi’s fitusiran, Cytokinetics’ aficamten await FDA approval

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Sevelamer

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 16 USDMF, 1 JDMF, 5 EU WC, 5 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

84 FDF Dossiers, 14 FDA Orange Book, 45 Europe, 1 Canada, 16 Australia, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG, TABLET;ORAL - 800MG

RELATED EXCIPIENT COMPANIES

2 DKSH, 1 Nanjing Well Pharmaceutical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 BASF, 1 Finar, 2 Gangwal Chemicals, 2 Microlex e.U, 4 Roquette, 1 Sigachi Industries, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

7 Film Formers & Plasticizers, 5 Coating Systems & Additives, 5 Lubricants & Glidants, 4 Topical, 3 Fillers, Diluents & Binders, 3 Emulsifying Agents, 3 Thickeners and Stabilizers, 2 Direct Compression, 2 Solubilizers, 1 Coloring Agents, 1 API Stability Enhancers, 1 Parenteral, 1 Granulation